Dr. Agarwal's FY26 PAT surges 52.4% to INR 168 Crores

1 min read     Updated on 28 May 2026, 09:14 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Dr. Agarwal's Health Care reported a 52.4% YoY increase in PAT to INR 168 Crores for FY26, driven by a 21.6% rise in revenue to INR 2,080 Crores. EBITDA grew 22.2% to INR 614 Crores with margins at 28.9%. The company added 57 new centers during the year, performing 323,245 surgeries.

powered bylight_fuzz_icon
40922181

*this image is generated using AI for illustrative purposes only.

Dr. Agarwal's Health Care reported a robust financial performance for the year ended March 31, 2026, with Profit After Tax (PAT) growing 52.4% year-on-year to INR 168 Crores. The company achieved a significant operational milestone, with Revenue from Operations increasing 21.6% to INR 2,080 Crores, crossing the INR 2,000 Crore mark for the first time. EBITDA for the period rose 22.2% to INR 614 Crores, with margins expanding to 28.9%. Following the announcement, the company has made the audio recording of its analyst and earnings conference call held on May 21, 2026, available on its website.

Annual Financial Performance

The audited consolidated financial results highlight strong growth across key metrics. Total Income for the year stood at INR 2,125 Crores, a 20.9% increase compared to the previous year. The company maintained its operational efficiency, with EBITDA margins improving slightly from 28.6% in FY25 to 28.9% in FY26. Net profit margins also saw a significant rise, reaching 7.9% for the year.

Metric (INR Crores) Year Ended Mar 31, 2026 Year Ended Mar 31, 2025 YoY Growth
Total Income 2,125 1,757 20.9%
Revenue from Operations 2,080 1,711 21.6%
EBITDA 614 502 22.2%
Profit After Tax 168 110 52.4%

Operational Expansion

During FY26, the company expanded its network significantly, adding 57 new centers to take its total facility count to 288 across 10 countries. This included 30 surgical centers, strengthening clinical capacity. The company performed 323,245 surgeries during the year, reflecting a 14.5% growth in patient volumes. The entry into the Delhi NCR region was a key highlight, with six facilities becoming operational within twelve months.

Q4 Performance Highlights

For the quarter ended March 31, 2026, the company reported a Revenue from Operations of INR 564 Crores, up 22.6% year-on-year. Net profit for the quarter stood at INR 50 Crores, growing 17.4% YoY. EBITDA for Q4 FY26 was INR 174 Crores, with margins at 30.2%. The company added 19 new centers during the quarter alone, comprising 7 secondary and 12 primary facilities.

Historical Stock Returns for Dr. Agarwal's Health Care

1 Day5 Days1 Month6 Months1 Year5 Years
-0.10%-2.72%-2.40%-11.79%+14.12%+9.37%

How will the recent entry into the Delhi NCR region impact the company's market share and competitive positioning in North India?

What is the expected capital expenditure for the next fiscal year to sustain the current pace of network expansion?

Will the company focus on acquiring smaller players or continue with its organic growth strategy to reach its target of 300+ centers?

Dr. Agarwal's Health Care
View Company Insights
View All News
like19
dislike

Dr. Agarwal's unit invests USD 2,00,000 in Ethiopia arm

1 min read     Updated on 27 May 2026, 07:17 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Orbit Healthcare Services (Mauritius) Limited, a wholly owned subsidiary of Dr. Agarwal's Health Care Limited, invested USD 2,00,000 in Orbit Health Care ETH PLC. The investment, completed on May 26, 2026, makes the Ethiopian entity a step-down wholly owned subsidiary.

powered bylight_fuzz_icon
41360987

*this image is generated using AI for illustrative purposes only.

Orbit Healthcare Services (Mauritius) Limited, a wholly owned subsidiary of dr. agarwal's health care , has completed an investment of USD 2,00,000 in Orbit Health Care ETH PLC. The investment was made towards the subscription of shares in the newly incorporated entity, as per prevailing currency rates. This strategic move expands the company's footprint into Ethiopia through its Mauritius-based subsidiary.

With this transaction, Orbit Health Care ETH PLC has become a wholly owned subsidiary of Orbit Healthcare Services (Mauritius) Limited. Consequently, the Ethiopian entity is now classified as an indirect and step-down wholly owned subsidiary of Dr. Agarwal's Health Care Limited. The intimation regarding the completion of this investment was received by the company on May 26, 2026.

Investment Structure

The investment follows the company's earlier communication dated February 03, 2026, regarding the proposed incorporation of a subsidiary in Ethiopia. The financial structure of the transaction is outlined below:

Entity Investment Status Relationship
Orbit Healthcare Services (Mauritius) Limited Investor Wholly owned subsidiary of Dr. Agarwal's Health Care Limited
Orbit Health Care ETH PLC Investee Wholly owned subsidiary of Orbit Healthcare Services (Mauritius) Limited

The disclosure was made to the exchanges in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Dr. Agarwal's Health Care

1 Day5 Days1 Month6 Months1 Year5 Years
-0.10%-2.72%-2.40%-11.79%+14.12%+9.37%

What is the projected timeline for the Ethiopian subsidiary to commence commercial operations?

How does Dr. Agarwal's plan to fund the operational setup and initial capital expenditure in Ethiopia?

What specific ophthalmic services will be prioritized in the Ethiopian market given the local healthcare needs?

Dr. Agarwal's Health Care
View Company Insights
View All News
like16
dislike

More News on Dr. Agarwal's Health Care

1 Year Returns:+14.12%